Eversept Partners, L.P., a Delaware limited partnership (“Eversept”), was founded in September 2015 by Kamran Moghtaderi to provide discretionary investment advisory services to pooled investment vehicles operating as private investment funds. Eversept currently sponsors the following U.S. and non-U.S. private investment funds, which it manages and directs the investment and reinvestment of assets for: o Eversept Global Healthcare Fund, L.P., a Delaware limited partnership (the “GHC Master Fund”); o Eversept Global Healthcare Offshore Fund, Ltd., a Cayman Islands exempted company (the “GHC Offshore Fund”, and together with the GHC Master Fund, the “GHC Funds” or the “GHC Fund”); o Eversept ELS Master Fund, L.P., a Cayman Islands exempted limited partnership (the “ELS Master Fund”); o Eversept ELS Offshore Fund, Ltd., a Cayman Islands exempted company (the “ELS Offshore Fund”, and together with the ELS Master Fund, the “ELS Funds” or the “ELS Fund”); o Eversept Generations Fund, L.P., a Delaware limited partnership (the “EGF Master Fund”, and together with the GHC Master Fund and ELS Master Fund, the “Master Funds” or the “Master Fund”); and o Eversept Generations Offshore Fund, Ltd., a Cayman Islands exempt company (the “EGF Offshore Fund” and together with EGF Master Fund, the “EGF Funds” or the “EGF Fund”). The EGF Funds follow a substantively similar investment strategy as the long only share class of the GHC Funds. The ELS Funds are a fund of one and managed for a single investor. Eversept also provides discretionary investment sub-advisory services to third-party funds (“Sub-Advised Funds”) which generally invest on a pari-passu basis with one or more of the Investment Funds (as defined below) in accordance with the terms of the respective sub-advisory agreement. An affiliate of Eversept, Eversept GP, LLC (“GP I”), a Delaware limited liability company, acts as the general partner of the GHC Master Fund, Eversept GP II, LLC (“GP II”), a Delaware limited liability company, acts as the general partner of ELS Master Fund, and Eversept GP III, LLC (“GP III”, together with GP I and GP II, the “GPs” or the “GP”), a Delaware limited liability company, acts as the general partner of EGF Master Fund. Kamran Moghtaderi is the managing principal of Eversept, and managing member of GP I, GP II ad GP III and directly and indirectly owns 100% of these entities. Each of the GHC Funds and the EGF Funds may be referred to individually in this Brochure as an “Eversept Fund” and together as the “Eversept Funds”. Each of the GHC Funds, the ELS Funds and the EGF Funds may be referred to individually in this Brochure as an “Investment Fund” and together as the “Investment Funds”. Each of the Investment Funds and the Sub-Advised Funds may be referred to individually in this Brochure as a “Fund” and together as the “Funds”. The terms for each Investment Fund are disclosed in detail in the relevant Investment Fund’s offering documents

that are provided to prospective investors prior to investment. Eversept acts as the investment manager of each Investment Fund and an investment sub-adviser to the Sub-Advised Funds. In the future, (i) Eversept or its affiliates may provide discretionary and/or non- discretionary investment advisory services to separately managed accounts (the “Managed Accounts”), (ii) Eversept or its affiliates may act in an investment advisory capacity to certain wholly-owned subsidiaries and trading vehicles of the Investment Funds used to carry out certain investment objectives of the Investment Funds, and (iii) Eversept or its affiliates may provide investment advisory services to other investment funds (all present and future advisory clients of Eversept, including the Funds and the Managed Accounts, the “Advisory Clients”). As further described in Item 8 below, the primary source of return generation of the Investment Funds comes from investing and trading in a broad array and type of securities and financial instruments, domestic and foreign, publicly traded or privately placed. Additionally, Eversept may allocate certain Funds’ capital to hedging activities designed to preserve capital and mitigate risk. The hedging activities may involve the Investment Funds owning financial instruments or entering into hedging agreements which may include a wide range of securities, options, futures, swaps and other assets Eversept deems appropriate. Generally, investors in any of the GHC or EGF Funds do not have the ability to individually tailor their investments or impose specific investment restrictions. However, when deemed appropriate, a GHC Fund may create a special class of interests or shares to accommodate a particular investor’s or a group of investors’ unique investment restrictions. From time to time the Funds also enter into side letters and other agreements and arrangements with certain investors which provide terms and conditions that are more advantageous than those set forth in the applicable Funds’ offering materials. Such terms and conditions may include special rights to make future investments in the Funds or other investment vehicles or accounts managed by Eversept, different transparency rights, reporting rights, and/or different fee terms. If Eversept establishes Managed Accounts, the investment objectives, fee arrangements and terms of Managed Accounts are individually negotiated, and any such Managed Account relationships may be subject to significant account minimums. Eversept does not participate in wrap fee programs. As of December 31, 2023, Eversept and its affiliates manage approximately $1.1 billion of Advisory Client assets on a discretionary basis and does not currently manage any assets on a non-discretionary basis. It should be noted that the assets under management disclosed here has been calculated differently than that of “regulatory assets under management” as disclosed in Eversept’s Form ADV Part 1, Item 5.F.